Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00963911 · OUTCOME

Specificity of the VES-13 Questionnaire

Validation of a Screening Tool in Geriatric Oncology · Source last updated 2021-04-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
% of Participants with a negative VES13
Interval / dispersion
95% Confidence Interval
Time frame
at inclusion (at completion of the G8 questionnaire)

What was measured

Specificity of the VES-13 questionnaire measure as the percentage of participants with a negative VES-13 test among patients with a negative MGA. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment. Multidimensional geriatric assessment (MGA): see measure description for primary outcome.

Analysis population: Eligible patients assessable for the primary endpoint (sensitivity of the G8 questionnaire) and with a negative MGA

Groups in this outcome

Eligible Patients Assessable for the Primary Outcome Measure

Patients older than 70 years and included either before any first-line treatment, or between any two steps of a pre-defined first-line treatment sequence (chemotherapy, endocrine therapy, targeted treatment, surgery or radiotherapy) for various types of histologically-confirmed cancer (colon, lung, upper aero digestive tract (UAT)/head and neck, breast, prostate, and non-Hodgkin's lymphomas (NHL)), and for whom G8 as well as at least one instrument of the multidimensional assessment were available.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Eligible Patients Assessable for the Primary Outcome Measure284

Reported measurements

Source class 1
Values in % of Participants with a negative VES13 · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Eligible Patients Assessable for the Primary Outcome Measure74.3Not reported68.879.3Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        68.8
        upper Limit
        79.3
        value
        74.3
denoms
  1. counts
    1. group Id
      OG000
      value
      284
    units
    Participants
description
Specificity of the VES-13 questionnaire measure as the percentage of participants with a negative VES-13 test among patients with a negative MGA. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \>=3 was considered to show impairment. Multidimensional geriatric assessment (MGA): see measure description for primary outcome.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients older than 70 years and included either before any first-line treatment, or between any two steps of a pre-defined first-line treatment sequence (chemotherapy, endocrine therapy, targeted treatment, surgery or radiotherapy) for various types of histologically-confirmed cancer (colon, lung, upper aero digestive tract (UAT)/head and neck, breast, prostate, and non-Hodgkin's lymphomas (NHL)), and for whom G8 as well as at least one instrument of the multidimensional assessment were available.
    id
    OG000
    title
    Eligible Patients Assessable for the Primary Outcome Measure
param Type
NUMBER
population Description
Eligible patients assessable for the primary endpoint (sensitivity of the G8 questionnaire) and with a negative MGA
reporting Status
POSTED
time Frame
at inclusion (at completion of the G8 questionnaire)
title
Specificity of the VES-13 Questionnaire
type
SECONDARY
unit Of Measure
% of Participants with a negative VES13

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice